{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T14:21:14Z","timestamp":1765808474131,"version":"3.41.2"},"reference-count":39,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T00:00:00Z","timestamp":1750723200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes &amp; Metabolism"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.diabet.2025.101682","type":"journal-article","created":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T19:02:38Z","timestamp":1750705358000},"page":"101682","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prediction of cardiovascular events by skin auto-fluorescence: the DIABAGE follow-up study"],"prefix":"10.1016","volume":"51","author":[{"given":"Jorys","family":"Bueno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alpha M.","family":"Diallo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phane","family":"Jaisson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenny","family":"Fontaine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9line","family":"Lukas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romain","family":"Barriquand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00e9raldine","family":"Vitellius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Gillery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brigitte","family":"Delemer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6987-9218","authenticated-orcid":false,"given":"Sara","family":"Barraud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabet.2025.101682_bib0001","first-page":"200\u20117","article-title":"Trends in childhood type 1 diabetes incidence in France, 2010\u20132015","volume":"149","author":"Piffaretti","year":"2019","journal-title":"Diabet Res Clin Pr."},{"key":"10.1016\/j.diabet.2025.101682_bib0002","doi-asserted-by":"crossref","first-page":"848\u201158","DOI":"10.1016\/S2213-8587(22)00276-5","article-title":"Estimating the total incidence of type 1 diabetes in children and adolescents aged 0-19 years from 1990 to 2050: a global simulation-based analysis","volume":"10","author":"Ward","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.diabet.2025.101682_bib0003","doi-asserted-by":"crossref","first-page":"2027\u201133","DOI":"10.1016\/S0140-6736(09)60568-7","article-title":"Incidence trends for childhood type 1 diabetes in Europe during 1989\u20132003 and predicted new cases 2005\u201320: a multicentre prospective registration study","volume":"373","author":"Patterson","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.diabet.2025.101682_bib0004","first-page":"686\u201193","article-title":"Intensive diabetes treatment and cardiovascular outcomes in type 1 diabetes: the DCCT\/EDIC Study 30-year follow-up","volume":"39","year":"2016","journal-title":"Diabet Care"},{"key":"10.1016\/j.diabet.2025.101682_bib0005","doi-asserted-by":"crossref","first-page":"39\u201143","DOI":"10.2337\/dc13-2116","article-title":"Update on cardiovascular outcomes at 30 years of the diabetes control and complications trial\/epidemiology of diabetes interventions and complications study","volume":"37","author":"Lachin","year":"2014","journal-title":"Diabet Care"},{"key":"10.1016\/j.diabet.2025.101682_bib0006","first-page":"493\u2011500","article-title":"The role of \u00ab metabolic memory \u00bb in the natural history of diabetes mellitus","volume":"119","author":"Drzewoski","year":"2009","journal-title":"Pol Arch Med Wewn"},{"key":"10.1016\/j.diabet.2025.101682_bib0007","doi-asserted-by":"crossref","first-page":"56\u201162","DOI":"10.1016\/j.jpeds.2016.01.066","article-title":"Early formation of serum advanced glycation end-products in children with type 1 diabetes mellitus: relationship with glycemic control","volume":"172","author":"Jaisson","year":"2016","journal-title":"J Pediatr"},{"key":"10.1016\/j.diabet.2025.101682_bib0008","doi-asserted-by":"crossref","first-page":"349\u201154","DOI":"10.1016\/j.diabet.2013.03.003","article-title":"Skin autofluorescence is associated with past glycaemic control and complications in type 1 diabetes mellitus","volume":"39","author":"Genevieve","year":"2013","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.diabet.2025.101682_bib0009","doi-asserted-by":"crossref","first-page":"33\u20118","DOI":"10.1515\/cclm-2012-0880","article-title":"Post-translational modification derived products (PTMDPs): toxins in chronic diseases?","volume":"52","author":"Gillery","year":"2014","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.diabet.2025.101682_bib0010","doi-asserted-by":"crossref","first-page":"813\u201120","DOI":"10.1038\/414813a","article-title":"Biochemistry and molecular cell biology of diabetic complications","volume":"414","author":"Brownlee","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.diabet.2025.101682_bib0011","doi-asserted-by":"crossref","first-page":"43\u201155","DOI":"10.1042\/CS20100501","article-title":"RAGE biology, atherosclerosis and diabetes","volume":"121","author":"Barlovic","year":"2011","journal-title":"Clin Sci"},{"key":"10.1016\/j.diabet.2025.101682_bib0012","doi-asserted-by":"crossref","first-page":"62\u20117","DOI":"10.1016\/j.mvr.2015.01.002","article-title":"Skin autofluorescence is associated with carotid intima-media thickness, diabetic microangiopathy, and long-lasting metabolic control in type 1 diabetic patients. Results from Poznan Prospective Study","volume":"98","author":"Araszkiewicz","year":"2015","journal-title":"Microvasc Res"},{"key":"10.1016\/j.diabet.2025.101682_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2024.101524","article-title":"Skin autofluorescence of advanced glycation end-products relates to new cardiovascular events in type 2 diabetes: a longitudinal observational study","volume":"50","author":"Alkhami","year":"2024","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.diabet.2025.101682_bib0014","doi-asserted-by":"crossref","first-page":"1324\u201130","DOI":"10.1007\/s00125-004-1451-2","article-title":"Simple non-invasive assessment of advanced glycation endproduct accumulation","volume":"47","author":"Meerwaldt","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabet.2025.101682_bib0015","doi-asserted-by":"crossref","first-page":"403\u20118","DOI":"10.1056\/NEJM198602133140702","article-title":"Relation between complications of type I diabetes mellitus and collagen-linked fluorescence","volume":"314","author":"Monnier","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabet.2025.101682_bib0016","doi-asserted-by":"crossref","first-page":"152\u20117","DOI":"10.1016\/j.diabet.2009.11.003","article-title":"Advanced glycation end products assessed by skin autofluorescence in type 1 diabetics are associated with nephropathy, but not retinopathy","volume":"36","author":"Chabroux","year":"2010","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.diabet.2025.101682_bib0017","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s12933-016-0448-8","article-title":"Skin autofluorescence predicts cardio-renal outcome in type 1 diabetes: a longitudinal study","volume":"15","author":"V\u00e9layoudom-C\u00e9phise","year":"2016","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.diabet.2025.101682_bib0018","doi-asserted-by":"crossref","first-page":"141\u20119","DOI":"10.1016\/j.jdiacomp.2012.10.004","article-title":"The association between skin collagen glucosepane and past progression of microvascular and neuropathic complications in type 1 diabetes","volume":"27","author":"Monnier","year":"2013","journal-title":"J Diabetes Complicat"},{"key":"10.1016\/j.diabet.2025.101682_bib0019","doi-asserted-by":"crossref","first-page":"266\u201178","DOI":"10.2337\/db14-0215","article-title":"Skin advanced glycation end products glucosepane and methylglyoxal hydroimidazolone are independently associated with long-term microvascular complication progression of type 1 diabetes","volume":"64","author":"Genuth","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.diabet.2025.101682_bib0020","doi-asserted-by":"crossref","first-page":"2331\u20116","DOI":"10.2337\/dc12-0053","article-title":"Skin intrinsic fluorescence is associated with coronary artery disease in individuals with long duration of type 1 diabetes","volume":"35","author":"Conway","year":"2012","journal-title":"Diabet Care"},{"key":"10.1016\/j.diabet.2025.101682_bib0021","doi-asserted-by":"crossref","first-page":"1531\u201146","DOI":"10.1007\/s13300-022-01285-1","article-title":"Association between the tissue and circulating advanced glycation end-products and the micro- and macrovascular complications in type 1 diabetes: the DIABAGE Study","volume":"13","author":"Diallo","year":"2022","journal-title":"Diabet Ther"},{"key":"10.1016\/j.diabet.2025.101682_bib0022","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.21105\/joss.01686","article-title":"Welcome to the tidyverse","volume":"4","author":"Wickham","year":"2019","journal-title":"J Open Sourc. Softw."},{"author":"Therneau","key":"10.1016\/j.diabet.2025.101682_bib0023"},{"key":"10.1016\/j.diabet.2025.101682_bib0024","doi-asserted-by":"crossref","first-page":"570\u201180","DOI":"10.32614\/RJ-2021-053","article-title":"Reproducible summary tables with the gtsummary package","volume":"13","author":"Sjoberg","year":"2021","journal-title":"R J"},{"key":"10.1016\/j.diabet.2025.101682_bib0025","doi-asserted-by":"crossref","unstructured":"Sjoberg D.D., Baillie M., Fruechtenicht C., Haesendonckx S., Treis T. ggsurvfit: flexible time-to-event figures [Internet] Available from: https:\/\/CRAN.R-project.org\/package=ggsurvfit; 2023.","DOI":"10.32614\/CRAN.package.ggsurvfit"},{"key":"10.1016\/j.diabet.2025.101682_bib0026","unstructured":"Robin X., Turck N., Hainard A., Tiberti N., Lisacek F., Sanchez J.C., et al. pROC: display and analyze ROC curves [Internet] Available from: http:\/\/expasy.org\/tools\/pROC\/; 2023."},{"year":"2023","series-title":"R: A Language And Environment For Statistical Computing [Internet]","key":"10.1016\/j.diabet.2025.101682_bib0027"},{"key":"10.1016\/j.diabet.2025.101682_bib0028","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12933-018-0718-8","article-title":"Skin autofluorescence predicts major adverse cardiovascular events in patients with type 1 diabetes: a 7-year follow-up study","volume":"17","author":"Blanc-Bisson","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.diabet.2025.101682_bib0029","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s12933-024-02316-w","article-title":"Protein glycation products associate with progression of kidney disease and incident cardiovascular events in individuals with type 1 diabetes","volume":"23","author":"Adeshara","year":"2024","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"10.1016\/j.diabet.2025.101682_bib0030","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12902-020-00676-4","article-title":"Skin autofluorescence predicts new cardiovascular disease and mortality in people with type 2 diabetes","volume":"21","author":"Boersma","year":"2021","journal-title":"BMC Endocr Disord"},{"issue":"2","key":"10.1016\/j.diabet.2025.101682_bib0031","doi-asserted-by":"crossref","first-page":"269\u201180","DOI":"10.1007\/s00125-018-4769-x","article-title":"Skin autofluorescence predicts incident type 2 diabetes, cardiovascular disease and mortality in the general population","volume":"62","author":"van Waateringe","year":"2019","journal-title":"Diabetologia"},{"issue":"6","key":"10.1016\/j.diabet.2025.101682_bib0032","doi-asserted-by":"crossref","first-page":"1532\u20117","DOI":"10.1161\/ATVBAHA.115.305407","article-title":"Skin autofluorescence as a measure of advanced glycation end products deposition predicts 5-year amputation in patients with peripheral artery disease","volume":"35","author":"de Vos","year":"2015","journal-title":"Arter. Thromb Vasc Biol"},{"issue":"4","key":"10.1016\/j.diabet.2025.101682_bib0033","doi-asserted-by":"crossref","first-page":"90\u2011102","DOI":"10.4330\/wjc.v4.i4.90","article-title":"Role of advanced glycation end products in cardiovascular disease","volume":"4","author":"Hegab","year":"2012","journal-title":"World J Cardiol"},{"key":"10.1016\/j.diabet.2025.101682_bib0035","doi-asserted-by":"crossref","first-page":"94\u2011108","DOI":"10.1016\/j.molmet.2013.11.006","article-title":"Vascular effects of advanced glycation endproducts: clinical effects and molecular mechanisms","volume":"3","author":"Stirban","year":"2014","journal-title":"Mol Metab"},{"key":"10.1016\/j.diabet.2025.101682_bib0036","first-page":"303\u201112","article-title":"Biomarkers in diabetes: hemoglobin A1c, vascular and tissue markers","volume":"15","author":"Lyons","year":"2012","journal-title":"Transl Res"},{"key":"10.1016\/j.diabet.2025.101682_bib40","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3389\/fcvm.2020.00037","article-title":"Receptor for Advanced Glycation End Products (RAGE) and Mechanisms and Therapeutic Opportunities in Diabetes and Cardiovascular Disease: Insights From Human Subjects and Animal Models","volume":"7","author":"Ega\u00f1a-Gorro\u00f1o","year":"2020","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.diabet.2025.101682_bib0039","doi-asserted-by":"crossref","first-page":"1058\u201166","DOI":"10.1161\/CIRCULATIONAHA.115.018844","article-title":"Prediction of first cardiovascular disease event in type 1 diabetes mellitus: the steno type 1 risk engine","volume":"133","author":"Vistisen","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.diabet.2025.101682_bib0037","doi-asserted-by":"crossref","first-page":"616\u201120","DOI":"10.1562\/0031-8655(2003)077<0616:IOETPA>2.0.CO;2","article-title":"Influence of epidermal thickness, pigmentation and redness on skin autofluorescence","volume":"77","author":"Sandby-M\u00f8ller","year":"2003","journal-title":"Photochem Photobiol"},{"key":"10.1016\/j.diabet.2025.101682_bib0038","doi-asserted-by":"crossref","first-page":"466\u201174","DOI":"10.1089\/dia.2012.0316","article-title":"Clinical and technical factors associated with skin intrinsic fluorescence in subjects with type 1 diabetes from the diabetes control and complications trial\/epidemiology of diabetes interventions and complications study","volume":"15","author":"Cleary","year":"2013","journal-title":"Diabetes Technol Ther"}],"container-title":["Diabetes &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S126236362500076X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S126236362500076X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T22:45:30Z","timestamp":1753310730000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S126236362500076X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S126236362500076X"],"URL":"https:\/\/doi.org\/10.1016\/j.diabet.2025.101682","relation":{},"ISSN":["1262-3636"],"issn-type":[{"type":"print","value":"1262-3636"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prediction of cardiovascular events by skin auto-fluorescence: the DIABAGE follow-up study","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabet.2025.101682","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"101682"}}